These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8584157)

  • 1. Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro.
    Hishii M; Nitta T; Ishida H; Ebato M; Kurosu A; Yagita H; Sato K; Okumura K
    Neurosurgery; 1995 Dec; 37(6):1160-6; discussion 1166-7. PubMed ID: 8584157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
    Zou JP; Morford LA; Chougnet C; Dix AR; Brooks AG; Torres N; Shuman JD; Coligan JE; Brooks WH; Roszman TL; Shearer GM
    J Immunol; 1999 Apr; 162(8):4882-92. PubMed ID: 10202033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.
    Morford LA; Dix AR; Brooks WH; Roszman TL
    J Neurosurg; 1999 Dec; 91(6):935-46. PubMed ID: 10584838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism.
    Baltuch GH; Villemure JG; McCrea E; Antel JP
    Neurosurgery; 1994 Sep; 35(3):450-6; discussion 456. PubMed ID: 7800136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro analysis of the proliferative potential of T cells from patients with brain tumor: glioma-associated immunosuppression unrelated to intrinsic cellular defect.
    McVicar DW; Davis DF; Merchant RE
    J Neurosurg; 1992 Feb; 76(2):251-60. PubMed ID: 1730954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
    Chirasani SR; Leukel P; Gottfried E; Hochrein J; Stadler K; Neumann B; Oefner PJ; Gronwald W; Bogdahn U; Hau P; Kreutz M; Grauer OM
    Int J Cancer; 2013 Feb; 132(4):843-53. PubMed ID: 22752934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced interleukin-1 beta release and longevity of glioma-associated peripheral blood monocytes in vitro.
    Fries G; Perneczky A; Kempski O
    Neurosurgery; 1994 Aug; 35(2):264-70; discussion 270-1. PubMed ID: 7969834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
    J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human glioma immunobiology in vitro: implications for immunogene therapy.
    Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
    Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
    Akbasak A; Oldfield EH; Saris SC
    J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune defects observed in patients with primary malignant brain tumors.
    Dix AR; Brooks WH; Roszman TL; Morford LA
    J Neuroimmunol; 1999 Dec; 100(1-2):216-32. PubMed ID: 10695732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of regulatory T-cells in glioma immunology.
    Ooi YC; Tran P; Ung N; Thill K; Trang A; Fong BM; Nagasawa DT; Lim M; Yang I
    Clin Neurol Neurosurg; 2014 Apr; 119():125-32. PubMed ID: 24582432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor.
    Elliott LH; Brooks WH; Roszman TL
    J Neurooncol; 1992 Sep; 14(1):1-7. PubMed ID: 1335042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and immunologic functions of Th17 cells in malignant gliomas.
    Paladugu M; Thakur A; Lum LG; Mittal S; Parajuli P
    Cancer Immunol Immunother; 2013 Jan; 62(1):75-86. PubMed ID: 22752645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.
    Domenis R; Cesselli D; Toffoletto B; Bourkoula E; Caponnetto F; Manini I; Beltrami AP; Ius T; Skrap M; Di Loreto C; Gri G
    PLoS One; 2017; 12(1):e0169932. PubMed ID: 28107450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of tumor necrosis factor-alpha on proliferation, cell surface antigen expression, and cytokine interactions in malignant gliomas.
    Chen TC; Hinton DR; Apuzzo ML; Hofman FM
    Neurosurgery; 1993 Jan; 32(1):85-94. PubMed ID: 8093640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.
    Kuppner MC; Hamou MF; Sawamura Y; Bodmer S; de Tribolet N
    J Neurosurg; 1989 Aug; 71(2):211-7. PubMed ID: 2545842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.